KELLIE AARONS

Allopathic & Osteopathic Physicians|Family Medicine TAMPA, FL NPI 1558865477

General Payments — all program years on this page

$1,105.68

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 59
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $415.15 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $415.1521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $31.542
2021 $86.364
2022 $176.2610
2023 $396.3722
2024 $415.1521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096618384 Novo Nordisk Inc $20.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096854148 Novo Nordisk Inc $14.00 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097562609 Novo Nordisk Inc $21.01 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103161154 ABBVIE INC. $15.35 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111507217 Amgen Inc. $15.36 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111507219 Amgen Inc. $13.21 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115977950 GlaxoSmithKline, LLC. $19.67 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117183407 Amgen Inc. $22.36 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118059283 Boehringer Ingelheim Pharmaceuticals, Inc. $16.60 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118847010 Otsuka America Pharmaceutical, Inc. $26.35 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118847012 Otsuka America Pharmaceutical, Inc. $14.71 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125126383 Abbott Laboratories $20.42 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132061326 PFIZER INC. $24.66 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135096902 Lilly USA, LLC $13.92 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135128676 Lilly USA, LLC $19.95 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148038269 Inspire Medical Systems, Inc. $39.57 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148038271 Inspire Medical Systems, Inc. $25.20 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148038273 Inspire Medical Systems, Inc. $17.34 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148038275 Inspire Medical Systems, Inc. $18.70 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148038277 Inspire Medical Systems, Inc. $17.69 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153313667 Dexcom, Inc. $18.56 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.